ARC-T

Welcome to the Brand page for “ARC-T”, which is offered here for Biological preparations for the treatment of cancer using genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands; pharmaceutical preparations for the purpose of binding ligands using receptors; pharmaceutical preparations for immunotherapy using genetically engineered cells;.

Its status is currently believed to be active. Its class is unavailable. “ARC-T” is believed to be currently owned by “Arcellx, Inc.”